[1]
|
Mollayeva, T., Mollayeva, S. and Colantonio, A. (2018) Traumatic Brain Injury: Sex, Gender and Intersecting Vulnera-bilities. Nature Reviews Neurology, 14, 711-722. https://doi.org/10.1038/s41582-018-0091-y
|
[2]
|
Bossers, S.M., Loer, S.A., Bloemers, F.W., et al. (2020) Association between Prehospital Tranexamic Acid Administration and Out-comes of Severe Traumatic Brain Injury. JAMA Neurology, 78, 338-345.
https://doi.org/10.1001/jamaneurol.2020.4596
|
[3]
|
Jiang, J.-Y., Gao, G.-Y., Feng, J.-F., et al. (2019) Traumatic Brain Injury in China. The Lancet Neurology, 18, 286-295.
https://doi.org/10.1016/S1474-4422(18)30469-1
|
[4]
|
National Center for Health Statistics: Mortality Data on CDC WONDER. Centers for Disease Control and Prevention.
https://wonder.cdc.gov/mcd.html
|
[5]
|
Bell, J.M., Breiding, M.J. and DePadilla, L. (2017) CDC’s Efforts to Im-prove Traumatic Brain Injury Surveillance. Journal of Safety Research, 62, 253-256. https://doi.org/10.1016/j.jsr.2017.04.002
|
[6]
|
Pearn, M.L., Niesman, I.R., Egawa, J., et al. (2017) Pathophysiology Associated with Traumatic Brain Injury: Current Treatments and Potential Novel Therapeutics. Cellular and Molecular Neurobiology, 37, 571-585.
https://doi.org/10.1007/s10571-016-0400-1
|
[7]
|
Eapen, B. and Cifu, D. (2018) Rehabilitation after Traumatic Brain Injury. Elsevier, St. Louis.
|
[8]
|
Cuccurullo, S.J. (2010) Traumatic Brain Injury. In: Cuccurullo, S.J., Ed., Physical Med-icine and Rehabilitation Board Review, 2nd Edition, Demos Medical Publishing, New York, 49-50, 51-53, 90-91.
|
[9]
|
Dixon, K.J. (2017) Pathophysiology of Traumatic Brain Injury. Physical Medicine and Rehabilitation Clin-ics of North America, 28, 215-225. https://doi.org/10.1016/j.pmr.2016.12.001
|
[10]
|
Chodobski, A., Zink, B.J. and Szmydynger-Chodobska, J. (2011) Blood-Brain Barrier Pathophysiology in Traumatic Brain Injury. Translational Stroke Research, 2, 492-516. https://doi.org/10.1007/s12975-011-0125-x
|
[11]
|
Yarlagadda, A., Alfson, E. and Clayton, A.H. (2009) The Blood Brain Barrier and the Role of Cytokines in Neuropsychiatry. Psychiatry (Edgmont), 6, 18-22.
|
[12]
|
Wong, A.D., Ye, M., Levy, A.F., et al. (2013) The Blood-Brain Barrier: An Engineering Perspective. Frontiers in Neuroengineering, 6, Article 7. https://doi.org/10.3389/fneng.2013.00007
|
[13]
|
Gayen, M., Bhomia, M., Balakathiresan, N. and Knollmann-Ritschel, B. (2020) Exosomal MicroRNAs Released by Activated Astrocytes as Potential Neuroinflammatory Biomarkers. International Journal of Molecular Sciences, 21, Article No. 2312. https://doi.org/10.3390/ijms21072312
|
[14]
|
Devoto, C., Arcurio, L., Fetta, J., Ley, M., Rodney, T., Kanefsky, R. and Gill, J. (2017) Inflammation Relates to Chronic Behavioral and Neurological Symptoms in Military Personnel with Traumatic Brain Injuries. Cell Transplantation, 26, 1169-1177. https://doi.org/10.1177/0963689717714098
|
[15]
|
Chiaretti, A., Antonelli, A., Mastrangelo, A., Pezzotti, P., Torto-rolo, L., Tosi, F. and Genovese, O. (2008) Interleukin-6 and Nerve Growth Factor Upregulation Correlates with Im-proved Outcome in Children with Severe Traumatic Brain Injury. Journal of Neurotrauma, 25, 225-234. https://doi.org/10.1089/neu.2007.0405
|
[16]
|
Hergenroeder, G.W., Moore, A.N., McCoy Jr., J.P., Samsel, L., Ward 3rd, N.H., Clifton, G.L. and Dash, P.K. (2010) Serum IL-6: A Candidate Biomarker for Intracranial Pressure Elevation Following Isolated Traumatic Brain Injury. Journal of Neuroinflammation, 7, Article No. 19. https://doi.org/10.1186/1742-2094-7-19
|
[17]
|
Mazzeo, A.T., Filippini, C., Rosato, R., Fanelli, V., Assenzio, B., Piper, I., Howells, T., Mastromauro, I., Berardino, M., Ducati, A. and Mascia, L. (2016) Multivariate Projection Method to Investigate Inflammation Associated with Secondary Insults and Outcome after Human Traumatic Brain Injury: A Pilot Study. Journal of Neuroinflammation, 13, Article No. 157. https://doi.org/10.1186/s12974-016-0624-5
|
[18]
|
Thompson, H.J., Martha, S.R., Wang, J. and Becker, K.J. (2020) Impact of Age on Plasma Inflammatory Biomarkers in the 6 Months Following Mild Traumatic Brain Injury. Journal of Head Trauma Rehabilitation, 35, 324-331.
https://doi.org/10.1097/HTR.0000000000000606
|
[19]
|
Stein, D.M., Lindell, A.L., Murdock, K.R., Kufera, J.A., Menaker, J., Bochicchio, G.V., Aarabi, B. and Scalea, T.M. (2012) Use of Serum Biomarkers to Predict Cerebral Hy-poxia after Severe Traumatic Brain Injury. Journal of Neurotrauma, 29, 1140-1149. https://doi.org/10.1089/neu.2011.2149
|
[20]
|
Shetty, T., Cogsil, T., Dalal, A., Kim, E., Halvorsen, K., Cummings, K. and Nguyen, J.T. (2019) High-Sensitivity C-Reactive Protein: Retrospective Study of Potential Blood Biomarker of In-flammation in Acute Mild Traumatic Brain Injury. Journal of Head Trauma Rehabilitation, 34, E28-E36. https://doi.org/10.1097/HTR.0000000000000450
|
[21]
|
Irrera, N., Russo, M., Pallio, G., et al. (2020) The Role of NLRP3 Inflammasome in the Pathogenesis of Traumatic Brain Injury. International Journal of Molecular Sciences, 21, Article No. 6204. https://doi.org/10.3390/ijms21176204
|
[22]
|
Wallisch, J.S., Simon, D.W., Bayır, H., Bell, M.J., Kochanek, P.M. and Clark, R.S.B. (2020) Cerebrospinal Fluid NLRP3 Is Increased after Severe Traumatic Brain Injury in Infants and Children. Neurocritical Care, 27, 44-50.
https://doi.org/10.1007/s12028-017-0378-7
|
[23]
|
Mishra, S.K., Kumar, B.S., Khushu, S., Singh, A.K. and Gangenahalli, G. (2020) Early Monitoring and Quantitative Evaluation of Macrophage Infiltration after Experimental Traumatic Brain Injury: A Magnetic Resonance Imaging and Flow Cytometric Analysis. Molecular and Cellular Neuro-science, 78, 25-34.
https://doi.org/10.1016/j.mcn.2016.11.008
|
[24]
|
Carabias, C.S., Gomez, P.A., Panero, I., Eiriz, C., Castaño-León, A.M., Egea, J. and Lagares, A. (2020) Chitinase-3-Like Protein 1, Serum Amyloid A1, C-Reactive Protein, and Procal-citonin Are Promising Biomarkers for Intracranial Severity Assessment of Traumatic Brain Injury: Relationship with Glasgow Coma Scale and Computed Tomography Volumetry. World Neurosurgery, 134, e120-e143. https://doi.org/10.1016/j.wneu.2019.09.143
|
[25]
|
Di Battista, A.P., Buonora, J.E., Rhind, S.G., Hutchison, M.G., Baker, A.J., Rizoli, S.B., Diaz-Arrastia, R. and Mueller, G.P. (2015) Blood Biomarkers in Moderate-to-Severe Traumatic Brain Injury: Potential Utility of a Multi-Marker Approach in Characterizing Outcome. Frontiers in Neurology, 6, Article 110. https://doi.org/10.3389/fneur.2015.00110
|
[26]
|
Gill, J., Latour, L., Diaz-Arrastia, R., Motamedi, V., Turtzo, C., Shahim, P., Mondello, S., DeVoto, C., Veras, E., Hanlon, D., Song, L. and Jeromin, A. (2018) Glial Fibrillary Acidic Protein Elevations Relate to Neuroimaging Abnormalities after Mild TBI. Neurology, 91, e1385-e1389. https://doi.org/10.1212/WNL.0000000000006321
|
[27]
|
Neri, M., Frati, A., Turillazzi, E., Cantatore, S., Cipolloni, L., Di Paolo, M., Frati, P., La Russa, R., Maiese, A., Scopetti, M., Santurro, A., Sessa, F., Zamparese, R. and Fineschi, V. (2018) Immunohistochemical Evaluation of Aquaporin-4 and Its Correlation with CD68, IBA-1, HIF-1α, GFAP, and CD15 Expressions in Fatal Traumatic Brain Injury. International Journal of Molecular Sciences, 19, Article No. 3544. https://doi.org/10.3390/ijms19113544
|
[28]
|
Bishop, P., Rocca, D. and Henley, J.M. (2016) Ubiquitin C-Terminal Hydrolase L1 (UCH-L1): Structure, Distribution and Roles in Brain Function and Dysfunction. Biochemical Journal, 473, 2453-2462.
https://doi.org/10.1042/BCJ20160082
|
[29]
|
Huibregtse, M.E., Bazarian, J.J., Shultz, S.R. and Kawata, K. (2021) The Biological Significance and Clinical Utility of Emerging Blood Biomarkers for Traumatic Brain Injury. Neuroscience & Biobehavioral Reviews, 130, 433-447.
https://doi.org/10.1016/j.neubiorev.2021.08.029
|
[30]
|
Paudel, Y.N., Angelopoulou, E., Piperi, C., Othman, I. and Shaikh, M.F. (2020) HMGB1-Mediated Neuroinflammatory Responses in Brain Injuries: Potential Mechanisms and Therapeutic Opportunities. International Journal of Molecular Sciences, 21, Article No. 4609. https://doi.org/10.3390/ijms21134609
|
[31]
|
Chirico, V., Lacquaniti, A., Salpietro, V., Munafò, C., Calabrò, M.P., Buemi, M., Arrigo, T. and Salpietro, C. (2014) High-Mobility Group Box 1 (HMGB1) in Childhood: From Bench to Bedside. European Journal of Pediatrics, 173, 1123-1136. https://doi.org/10.1007/s00431-014-2327-1
|
[32]
|
Bohnert, S., Seiffert, A., Trella, S., Bohnert, M., Distel, L., Ondruschka, B. and Monoranu, C.-M. (2020) TMEM119 as a Specific Marker of Microglia Reaction in Traumatic Brain Injury in Postmortem Examination. International Journal of Legal Medicine, 134, 2167-2176. https://doi.org/10.1007/s00414-020-02384-z
|
[33]
|
Lorente, L. (2015) New Prognostic Biomarkers in Patients with Traumatic Brain Injury. Archives of Trauma Research, 4, e30165. https://doi.org/10.5812/atr.30165
|
[34]
|
Lorente, L., Martín, M.M., Pérez-Cejas, A., González-Rivero, A.F., Argueso, M., Ramos, L., Solé-Violán, J., Cáceres, J.J., Ji-ménez, A. and García-Marín, V. (2019) Persistently High Serum Substance P Levels and Early Mortality in Patients with Severe Traumatic Brain Injury. World Neurosurgery, 132, e613-e617.
https://doi.org/10.1016/j.wneu.2019.08.064
|
[35]
|
Sedger, L.M. and McDermott, M.F. (2014) TNF and TNF-Receptors: From Mediators of Cell Death and Inflammation to Therapeutic Giants—Past, Present and Future. Cyto-kine & Growth Factor Reviews, 25, 453-472.
https://doi.org/10.1016/j.cytogfr.2014.07.016
|
[36]
|
Vijapur, S.M., Vaughan, L.E., Awan, N., DiSanto, D., McKernan, G.P. and Wagner, A.K. (2021) Treelet Transform Analysis to Identify Clusters of Systemic Inflammatory Variance in a Population with Moderate-to-Severe Traumatic Brain Injury. Brain, Behavior, and Immunity, 95, 45-60. https://doi.org/10.1016/j.bbi.2021.01.026
|